Your Expert Partner for Custom Binding Assays and Reagents
Flexible phage solutions.
Precision affinity reagents.
Tango Biosciences leads the industry with an innovative approach to phage display that delivers highly sensitive, specific, and reproducible custom affinity reagents for your target or antigen. Whether you are developing research tools, diagnostic assays, or therapeutics, Tango Biosciences’ sustainable recombinant affinity reagents and assay development solutions deliver more reliable results faster than any other company.
News and Events
-
NIH Awards New SBIR Grant
The National Institutes of Health (NIH) awarded a phase I SBIR grant to Tango Biosciences in July 2025. This award will support the application of Tango Biosciences’ proprietary Avidimer platform for the development of protein tools that enhance the discovery of proximity inducing modalities such as molecular glues. The Avidimers developed in this program will generate proof-of-concept…
-
Tango Biosciences Appoints Zachary Gurard-Levin, PhD to Board of Directors
Appointment Brings Over Ten Years as a CRO Executive Tango Biosciences, Inc., the premier contract research organization for custom affinity reagents by phage display, announced the appointment of Zachary Gurard-Levin, PhD, to its board of directors effective immediately. Gurard-Levin brings over two decades of experience in assay development and driving successful research programs for biotech…
-
ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025
Chicago, IL | May 12-15, 2025 Join Tango Biosciences at ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025! Booth CP3 This meeting attracts a highly targeted audience composed of experts and researchers in drug discovery and development. Visit the Tango Biosciences booth to talk to our experts in peptide therapeutics discovery, targeted protein degradation for PROTACs and molecular glues,…